Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction.

[1]  E. Braunwald,et al.  Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction. , 1998, Circulation.

[2]  C. Patrono,et al.  Platelet activation and inhibition in unstable coronary syndromes. , 1997, The American journal of cardiology.

[3]  T. Investigators.  Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. , 1997, Circulation.

[4]  G. Lip,et al.  Hypothesis: is soluble P-selectin a new marker of platelet activation? , 1997, Atherosclerosis.

[5]  T. Iwasaka,et al.  Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease , 1996, European journal of clinical investigation.

[6]  N. Kleiman,et al.  Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary intervention. , 1996, Circulation.

[7]  F. Gries,et al.  PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) , 1996, European heart journal.

[8]  A. Michelson.  Flow cytometry: a clinical test of platelet function. , 1996, Blood.

[9]  M. Macey,et al.  Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  T. Ueno,et al.  Increased soluble form of P-selectin in patients with unstable angina. , 1995, Circulation.

[11]  P. Nurden,et al.  Flow cytometry reveals activated GP IIb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  Y. Koga,et al.  Soluble form of P-selectin in patients with acute myocardial infarction. , 1994, Coronary artery disease.

[13]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[14]  K. Mann,et al.  The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes , 1994, Coronary artery disease.

[15]  P. Nurden,et al.  Markers of platelet activation in coronary heart disease patients , 1994, European journal of clinical investigation.

[16]  K. Ault,et al.  Analysis of platelets by flow cytometry. , 1994, Methods in cell biology.

[17]  K. Ault.  Flow Cytometric Measurement of Platelet Function and Reticulated Platelets , 1993, Annals of the New York Academy of Sciences.

[18]  R. Hillman,et al.  Platelet activation and aggregation during cardiopulmonary bypass. , 1991, Anesthesiology.

[19]  C. Abrams,et al.  Immunological Detection of Activated Platelets in Clinical Disorders , 1991, Thrombosis and Haemostasis.

[20]  N. Rote,et al.  Production of monoclonal antibodies specific for platelet activation antigens and their use in evaluating platelet function. , 1990, Hybridoma.

[21]  J. Schapiro,et al.  Platelet hyperreactivity and prognosis in survivors of myocardial infarction. , 1990, The New England journal of medicine.

[22]  C. Abrams,et al.  Direct detection of activated platelets and platelet-derived microparticles in humans. , 1990, Blood.

[23]  C. Lambrew,et al.  Correlated measurement of platelet release and aggregation in whole blood. , 1989, Cytometry.

[24]  J. Hoxie,et al.  Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry , 1987 .

[25]  L Roy,et al.  Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.

[26]  R. McEver,et al.  A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. , 1984, The Journal of biological chemistry.